COMPANY PROFILE

Qubit Pharmaceuticals

Explore full profile

Quantum physics and AI-driven drug discovery platform

Paris, FranceFounded 2020Biotech & Life Sciences

Valuation $50–100M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Qubit Pharmaceuticals

Developer of drug discovery simulation platform designed to reduce the cost and length of preclinical drug development. The company's platform uses proprietary force field models and molecular dynamics calculations and performs virtual screening, and visualization, to find valuable candidates, enabling biopharmaceutical companies to get support in their research and development by accelerating drug discovery with quantum physics. Keywords: Software, Fintech, Security and Connectivity, Drug Development System, Drug Development Tool, Drug Discovery Platform, Drug Discovery Software, Drug Discovery Technology, Hpc Software, Machine Learning Solutions, Quantum Computing Application.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Paris, France
Employees: 60
Open positions: None listed
Dealroom signal: 61.2/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Drug Development, Research and Development, Quantum Computing, Molecular Biology
Technology: Hardware, 3D Technology, Deep Tech, Quantum Technologies
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Jun 2022	$18M	$70M	Octave Klaba · Quantonation · Omnes Capital · XAnge	↗
GRANT✓Other financing	Jun 2021	$2.5M	—	European Innovation Council	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Qubit Pharmaceuticals website traffic

Latest recorded traffic for Qubit Pharmaceuticals is 6.1K monthly website visits, up 110.3% over the last three months. Qubit Pharmaceuticals's team declined 7.7% over the past year.

Latest monthly visits6.1K 3-month web change+110.3% 1-year team growth-7.7%

Monthly website visitsDec 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
WGWhitelab GenomicsAI platform for accelerating genomic medicine development	Évry-Courcouronnes, France	Operational	54	$11M	$40M
PHPharmaceleraQuantum mechanics and AI powered drug discovery platform	Barcelona, Spain	Operational
AQAqemiaUsing quantum-physics with AI to speed up the discovery of novel drug molecules	Paris, France	Operational
OWOwkinCollaborative research platform and unique AI drug development solutions that make precision medicine a reality	Paris, France	Operational
BIBioSimulyticsIn-silico drug development for API small molecules ⚛️	Dublin, Ireland	Operational
MAMAbSilicoComputational solutions for antibody discovery using Artificial Intelligence and Machine Learning	Tours, France	Operational
IKIktosSpecializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design	Paris, France	Operational
ABArthex BiotechFocused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat diseases with unmet medical needs	Paterna, Spain	Operational